NCT07291765 Blood Flow Restriction Training in Acute Geriatric Rehabilitation
| NCT ID | NCT07291765 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Sarcopenia in Elderly |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Older adults have a reduced ability to build and maintain muscle mass due to age-related changes in the muscular system. The resulting sarcopenia can lead to a number of health problems and limitations, such as an increased risk of falling and reduced mobility, which can affect quality of life and increase the risk of disease. To increase muscle mass and strength, high-intensity resistance training with loads of 70 to 85% of the repetition maximum (1RM) is recommended. However, this type of training poses a major challenge in the rehabilitation sector, as there is also an increased risk of injury due to physical limitations in old age. According to current research, low-intensity occlusion training could therefore represent a safe and effective training alternative. The aim of this study is therefore to examine the feasibility and effects of blood flow restriction training (BFR) on general health in older adults in a rehabilitative setting.
Eligibility Criteria
Inclusion Criteria: * Adults \>65 years with a two week hospitalized acute rehabilitation after a fracture closed to the hip joint Exclusion Criteria: * Sickle Cell Anemia * Iatrogenic changes of the vessels at the place of the tournqiuet application (e.g. Stents)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07291765 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Sarcopenia in Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07291765 currently recruiting?
Yes, NCT07291765 is actively recruiting participants. Contact the research team at alexander.franz@ukbonn.de for enrollment information.
Where is the NCT07291765 trial being conducted?
This trial is being conducted at Cologne, Germany.
Who is sponsoring the NCT07291765 clinical trial?
NCT07291765 is sponsored by University Hospital, Bonn. The trial plans to enroll 60 participants.